We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $15.1B
1-Year Est. Return 27.93%
This Fund
S&P 500
This Quarter Est. Return
+16%
1 Year Est. Return
+27.93%
3 Year Est. Return
+64.69%
5 Year Est. Return
+64.07%
10 Year Est. Return
–
AUM
$15.1B
AUM Growth
+$11.5B
Cap. Flow
+$10.9B
Cap. Flow %
71.99%
Top 10 Hldgs %
18.25%
Holding
5,282
New
1,517
Increased
3,296
Reduced
222
Closed
78

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$331M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$324M
3
NVDA icon
NVIDIA
NVDA
+$260M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$219M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$172M

Top Sells

Rank Stock Value
1
HIMU
iShares High Yield Muni Active ETF
HIMU
+$4.53M
2
VBR icon
Vanguard Morningstar Small-Cap Value ETF
VBR
+$3.23M
3
DFEM icon
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
+$2.25M
4
VOE icon
Vanguard Morningstar Mid-Cap Value ETF
VOE
+$2.21M
5
CGGR icon
Capital Group Growth ETF
CGGR
+$1.45M

Sector Composition

Rank Sector Weight
1 Miscellaneous 51.68%
2 Technology 13.1%
3 Industrials 6.81%
4 Financials 6.59%
5 Energy 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DMRA
5126
Damora Therapeutics
DMRA
$1.79B
$130 ﹤0.01%
+5
New +$121
XOMA
5127
DELISTED
Xoma
XOMA
$128 ﹤0.01%
+3
New +$122
OPENL
5128
Opendoor Technologies Inc Series A Warrants
OPENL
$3.97M
$126 ﹤0.01%
444
+385
+653% +$118
RSEE icon
5129
Rareview Systematic Equity ETF
RSEE
$74.5M
$119 ﹤0.01%
+3
New +$113
AREN icon
5130
Arena Group
AREN
$53.3M
$113 ﹤0.01%
+136
New +$236
INO icon
5131
Inovio Pharmaceuticals
INO
$133M
$113 ﹤0.01%
+103
New +$122
YOLO icon
5132
AdvisorShares Pure Cannabis ETF
YOLO
$36.4M
$110 ﹤0.01%
38
+31
+443% +$92
MOBX icon
5133
Mobix Labs
MOBX
$18.8M
$109 ﹤0.01%
+52
New +$125
ESPR
5134
DELISTED
Esperion Therapeutics
ESPR
$107 ﹤0.01%
+34
New +$95
OPENZ
5135
Opendoor Technologies Inc Series Z Warrants
OPENZ
$4.12M
$107 ﹤0.01%
444
+440
+11,000% +$126
TEO icon
5136
Telecom Argentina
TEO
$5.63B
$104 ﹤0.01%
+8
New +$101
PRSO icon
5137
Peraso
PRSO
$9.68M
$101 ﹤0.01%
+111
New +$109
RTRE
5138
Rareview Total Return Bond ETF
RTRE
$59.9M
$100 ﹤0.01%
+4
New +$100
LXRX icon
5139
Lexicon Pharmaceuticals
LXRX
$1.02B
$98 ﹤0.01%
41
– –
KYTX icon
5140
Kyverna Therapeutics
KYTX
$518M
$98 ﹤0.01%
11
– –
CVGI icon
5141
Commercial Vehicle Group
CVGI
$127M
$93 ﹤0.01%
+20
New +$94
BLNK icon
5142
Blink Charging
BLNK
$77.2M
$92 ﹤0.01%
143
+38
+36% +$28
CCCC icon
5143
C4 Therapeutics
CCCC
$474M
$89 ﹤0.01%
19
-300
-94% -$1.03K
ALMU
5144
Aeluma Inc
ALMU
$241M
$88 ﹤0.01%
+4
New +$86
HELP
5145
Cybin Inc
HELP
$890M
$86 ﹤0.01%
+13
New +$65
ROE icon
5146
Astoria US Quality Kings ETF
ROE
$281M
$85 ﹤0.01%
+2
New +$80
TLPH icon
5147
Talphera
TLPH
$62.3M
$83 ﹤0.01%
81
– –
KRMD icon
5148
KORU Medical Systems
KRMD
$149M
$79 ﹤0.01%
+19
New +$78
PSIX
5149
Power Solutions International
PSIX
$837M
$78 ﹤0.01%
+2
New +$110
ABOS icon
5150
Acumen Pharmaceuticals
ABOS
$211M
$69 ﹤0.01%
26
– –
204 205
206
207 208

Similar funds

VIM
Vinva Investment Management Sydney, Australia $15.1B AUM 39.47% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
TWIM
TIAA Wealth Investment Management New York $15B AUM
IFP
Independent Franchise Partners London, United Kingdom $15.2B AUM 1.56% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $15.3B AUM 24.71% 1-Year Est. Return

Arax Advisory Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Arax Advisory Partners held 5,282 positions worth $15.1B, up 326% from $3.54B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Arax Advisory Partners deployed $10.9B of net new capital in Q2 2026, opening 1,517 new positions and adding to 3,296 existing holdings. Its largest new stake was ClearShares Piton Intermediate Fixed Income ETF: 984,286 shares worth $92M.

By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, down from 70% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares High Yield Muni Active ETF, an estimated $4.53M trimmed.

  • Arax Advisory Partners's largest Q2 2026 buy was ClearShares Piton Intermediate Fixed Income ETF: 984,286 shares worth $92M.
  • Arax Advisory Partners added most to Apple in Q2 2026, an estimated $331M increase.
  • Arax Advisory Partners's biggest Q2 2026 reduction was iShares High Yield Muni Active ETF, cutting an estimated $4.53M.
  • Arax Advisory Partners fully exited Monroe Capital Corp in Q2 2026, selling an estimated $379K.
  • Arax Advisory Partners's ten largest holdings make up 18% of its $15.1B portfolio in Q2 2026.
  • Arax Advisory Partners opened 1,517 new positions and closed 78 in Q2 2026.
  • Arax Advisory Partners's portfolio value rose 326% quarter-over-quarter to $15.1B.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.